Mastering the Management of ASCVD Risk
This NEW Clinician’s Learning Center is a destination site for aggregated CME education where we will explore the challenges facing healthcare professionals involved in managing the care of patients with Atherosclerotic Cardiovascular Disease (ASCVD) risk. After learning about the latest guideline recommendations and new ASCVD risk reduction clinical trial data, participants will be better able to integrate this advancing knowledge into their clinical practice to increase the number of patients at risk of ASCVD who are receiving the most appropriate, optimal therapy.
Check out the Featured Programs below and stay tuned for new programs launching this year.
“The best intervention is prevention! However, many patients with ASCVD or at high risk for ASCVD are suboptimally treated and have residual burden of atherogenic lipid particles. While statin therapy remains firstline therapy on top of healthy lifestyle for lipid management for ASCVD prevention, it is critical to address patients’ residual risk and multi-morbidity through a multipronged approach.”
-Erin Michos, MD
Featured Activities View ASCVD Activity Library
Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction with Icosapent Ethyl in Post-MI Patients: Key Takeaways
Host: William Boden, MD, FACC, FAHA
Addressing late-breaking data on triglycerides, fibrates and omega-3FAs
Host: Peter Libby, MD
Guests: Gabriel Steg, MD and Kausik Ray, MD
Mechanistic clues to understanding the benefits of icosapent ethyl
Host: Matthew J Budoff, MD
Guest: David Geffen, MD